Does RIBOCICLIB Cause Hepatic function abnormal? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Hepatic function abnormal have been filed in association with RIBOCICLIB (KISQALI). This represents 0.2% of all adverse event reports for RIBOCICLIB.
68
Reports of Hepatic function abnormal with RIBOCICLIB
0.2%
of all RIBOCICLIB reports
11
Deaths
20
Hospitalizations
How Dangerous Is Hepatic function abnormal From RIBOCICLIB?
Of the 68 reports, 11 (16.2%) resulted in death, 20 (29.4%) required hospitalization, and 2 (2.9%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which RIBOCICLIB Alternatives Have Lower Hepatic function abnormal Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN